Skip to main content
OpenTrials

Clinical trial condition

Basal Ganglia Diseases

Explore clinical trials studying Basal Ganglia Diseases. Study availability and eligibility vary by location and protocol.

4,056 public trials 750 recruiting studies
Refine in advanced search Browse all conditions

Basal Ganglia Diseases trial results

Completed

Effectiveness Study of Occupational Therapy in Parkinson's Disease

NCT01336127

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Meander Medisch Centrum Amersfoort, Netherlands
  • Gelre Ziekenhuizen Apeldoorn, Netherlands
  • Tergooiziekenhuizen Blaricum, Netherlands
  • Deventer Ziekenhuis Deventer, Netherlands
View Trial Details
Completed

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period Dyskinesias

NCT01172379

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Clinic of Neurology, Faculty Hospital Olomouc Olomouc, Czechia
  • Private Neurology Practise Ostrava, Czechia
  • Department of Neurology, Regional Hospital Pardubice Pardubice, Czechia
  • First Faculty of Medicine Charles University Prague, Czechia
View all 33 locations
View Trial Details
Completed

Survey on PD Patients With Depressive Symptoms

NCT00614575

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Boehringer Ingelheim Investigational Site Akashi, Japan
  • Boehringer Ingelheim Investigational Site 1 Akita, Japan
  • Boehringer Ingelheim Investigational Site 2 Akita, Japan
  • Boehringer Ingelheim Investigational Site Asahikawa, Japan
View all 238 locations
View Trial Details
Completed

A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period

NCT00560508

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • 248.610.019 Boehringer Ingelheim Investigational Site Akashi, Hyogo, Japan
  • 248.610.020 Boehringer Ingelheim Investigational Site Akita, Akita, Japan
  • 248.610.006 Boehringer Ingelheim Investigational Site Aomori, Aomori, Japan
  • 248.610.017 Boehringer Ingelheim Investigational Site Asahikawa, Hokkaido, Japan
View all 19 locations
View Trial Details

Related conditions